Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd. on August 1, 2017, covering the month of August 2017. The registrant is a foreign private issuer based in Kfar Saba, Israel. The filing reports on corporate governance actions taken during the period.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a report of a shareholder meeting and does not contain financial statements or performance metrics.
Material Changes
On July 31, 2017, the Company convened an Extraordinary Meeting of Shareholders. Ordinary shareholders and ADS holders passed all agenda items as originally proposed. Details regarding these items are referenced in Exhibit 99.1 of a prior Form 6-K filed on June 26, 2017.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document focuses solely on the confirmation of shareholder vote results.
Key Investor Verification Points
- Verify the specific agenda items approved by shareholders by reviewing Exhibit 99.1 of the Form 6-K filed on June 26, 2017.
- Confirm the implementation timeline for the approved shareholder resolutions.
- Note that this filing contains no financial data; refer to the most recent Form 20-F for financial performance.